Journals / MN Oftalmoloji / 2016 / Cilt: 23 - Sayı: 1

The Pathophysiology and Classification of Dry Eye

Kuru Göz Oluşum Mekanizması ve Sınıflandırılması

Pages
1–8
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However frequently these two types overlap bothin etiopathogenesis and clinical picture

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Dry eye syndrome (DES) has been recently defined as “a multifactorial disease of the tears and ocular surface that resultsin symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface.” It isaccompanied by increased osmolarity of the tear film and inflammation of the ocular surface.
📊
Key Findings & Data:The inflammatory members in DES pathogenesis involve both cells (lymphocytes, dendritic cells, langerhans cells, macrophages, antigen presenting cells like T cells(TH1, Th17, Treg) and ocular surface epithelial cells) and inflammatory mediators (cytokines, chemokines and their receptors, matrix metalloproteinases and secreted phospholipases).
💡
Conclusion & Impact:However frequently these two types overlap bothin etiopathogenesis and clinical picture
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Dry eye syndrome (DES) has been recently defined as “a multifactorial disease of the tears and ocular surface that resultsin symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface.” It isaccompanied by increased osmolarity of the tear film and inflammation of the ocular surface. It is estimated that one thirdof the adult population in the whole world has DES. The immunopathogenic basis of the DES involves impaired stability andhyperosmolarity of the tear film secondary to the inflammatory disease or damage of any component of the lacrimal functional unit. The resultant inflammatory vicious cycle can lead to ocular surface disease that manifests itself as dry eye. DES,not only impairs the quality of life with the discomfort it causes, but also threatens vision by complications like corneal ulceration or melting, particularly in case of underlying inflammatory processes. The inflammatory members in DES pathogenesis involve both cells (lymphocytes, dendritic cells, langerhans cells, macrophages, antigen presenting cells like T cells(TH1, Th17, Treg) and ocular surface epithelial cells) and inflammatory mediators (cytokines, chemokines and their receptors, matrix metalloproteinases and secreted phospholipases). Today, HLA-DR-positive cells and tear cytokine expression arebeing studied as minimally invasive objective bio-markers, for their role in DES severity classification, research on mechanism of DES development, and evaluation of the treatment responses. In ophthalmology practice, DES classification as“aqueous deficieny” and “hyperevaporative” types has been internalized. However frequently these two types overlap bothin etiopathogenesis and clinical picture

Özet

Kuru göz sendromunun (KGS) güncel tanımı"oküler yüzeye potansiyel hasarı olabilecek, rahatsızlık hissi, görsel bozuklukve gözyaşı filminin dayanıksızlığına neden olan, gözyaşı ve oküler yüzeyin çok-faktörlü bir hastalığı" olarak yapılmıştır.Gözyaşı filminin artmış ozmolaritesi ve oküler yüzeyin inflamasyonu ile birliktedir. Tüm dünyada erişkin popülasyonun üçtebirine varan oranlarda KGS görülebildiği tahmin edilmektedir. KGS'nin immünopatojenik temeli, lakrimal fonksiyonel birimin herhangi bir bileşeninin inflamatuvar hastalığı veya hasarına ikincil gözyaşı film tabakasının durağanlığının bozulmasıve hiperozmolaritesini içerir. Sonuçta oluşan inflamatuvar kısır döngü, kendini kuru göz olarak gösteren oküler yüzey hastalığına yol açabilir. KGS, sadece verdiği rahatsızlığa bağlı olarak hayat kalitesini azaltmakla kalmaz; özellikle altta yatansistemik inflamatuvar süreç varlığında, korneada ülser oluşumu ve erime gibi komplikasyonlar ile görmeyi tehdit eder. KGSpatogenezindeki inflamatuvar elemanlar hem hücreler (lenfositler, dendritik hücreler, langerhans hücreleri, makrofajlar, Thücreleri (Th1, Th17, Treg) gibi antijen sunan hücreler ve oküler yüzey epitel hücreleri) hem de inflamatuvar medyatörlerdir(sitokinler, kemokinler ve reseptörleri, matrix metalloproteinazlar ve salgılanan fosfolipazlar). Günümüzde HLA-DR-pozitifhücrelerin ve gözyaşı sitokin ekspresyonunun, KGS şiddetinin sınıflandırılması, oluşma mekanizmalarının araştırılması vetedavi yanıtlarının değerlendirilmesi için minimal invazif objektif biyo-işaretleyiciler olarak araştırılmaktadır. Oftalmolojipratiğinde KGS'nin "aköz yetmezlik" ve "hiperevaporatif" tipler olarak sınıflanması benimsenmiştir. Ancak sıklıkla bu ikitip, etyopatogenez ve klinik tabloda birbiri ile kesişirler

🔖

Cite This Article

UTİNE, C. A. (2016). The Pathophysiology and Classification of Dry Eye. MN Oftalmoloji, Cilt: 23 - Sayı: 1, 1–8. https://ajindex.com/articles/296726

References (16)

  1. The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf 2007;5:75-92
  2. Sjögren H. Zur Kenntnis dur keratoconjunctivitis sicca (keratitis filiformis bei hypofunktion der Tranendrü - sen). Acta Ophthalmol 1933;(11 Suppl 2):1-151
  3. Yokoi N, Kinoshita S, Sakai R, et al. A comparative study between short breakup time dry eye and other disorders giving rise to a short breakup. Invest Ophthalmol Vis Sci 2011;52: E-Abstract 3854
  4. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25:900-7
  5. Clegg JP, Guest JF, Lehman A, et al. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol 2006;13:263-74
  6. The epidemiology of dry eye disease: report of the rpidemiology subcommittee of the international dry eye workshop. Ocul Surf 2007;5:93-107
  7. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997;74:624-31
  8. Schaumberg DA, Sullivan DA, Dana MR. Epide mio - logy of dry eye syndrome. Adv Exp Med Biol 2002; 506:989-98
  9. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmology 2000;118:1264-8
  10. Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013;32:19-41
  11. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immunemediated ocular surface disorder. Arch Ophthalmol 2012;130:90-100
  12. Akpek EK, Klimava A, Thorne JE, Martin D, Lekha - nont K, Ostrovsky A. Evaluation of patients with dry eye for presence of underlying Sjogren’s Syndrome. Cornea 2009;28:493-7
  13. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immunemediated ocular surface disorder. Arch Ophthalmol 2012;130:90-100
  14. Messmer EM. The pathophysiology, diagnosis and treatment of dry eye disease. Dtsch Arztebl Int 2015;112:71-82
  15. Wei Y, Asbell PA. The core mechanism of dry eye disease (DED) is inflammation. Eye Contact Lens 2014;40:248-56
  16. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1 beta generation. Clin Exp Im - mu nol 2007;147:227-35